Aug 7 (Reuters) - The third trial over claims that discontinued heartburn drug Zantac ended in a mistrial on Wednesday when jurors could not agree about whether pharmaceutical company Boehringer ...

Swoop and iSpot have joined forces to deliver insights into cross-platform ad exposures against specific audiences for healthcare and pharma marketers. Through the newly announced partnership, ...

Patients allege that heartburn drug caused their cancer Court says expert opinions not backed by reliable science FDA asked in 2020 that Zantac be pulled from market Patients' lawyer says scientific ...

On Wednesday, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% of ...

He is accusing GSK, formerly known as GlaxoSmithKline, of hiding the cancer risks of its once-popular heartburn drug, Zantac. Yost filed a motion on Monday requesting that the Ohio Public Employees ...

In a significant legal win for GSK plc (NYSE:GSK), on Friday, a Florida State Court ruled in favor of the pharmaceutical giant, excluding the plaintiff’s expert testimonies that claimed ranitidine, a ...

Over the counter Zantac used for acid reflux and heartburn. The future of thousands of lawsuits alleging that recalled heartburn medication Zantac causes cancer is becoming more uncertain after an ...

British drugs firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new lawsuit has claimed. A pension fund has filed a class action against ...

Ohio Attorney General Dave Yost is pushing to lead a class-action lawsuit against a pharmaceutical company. [DOWNLOAD: Free WHIO-TV News app for alerts as news breaks] He is accusing GSK, formerly ...